Cargando…

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients

Several studies have evaluated the efficacy of neoadjuvant treatment using oxaliplatin and fluoropyrimidines in advanced gastric cancer (GC). However, preoperative biomarkers predictive of clinical outcome remain lacking. We examined polymorphisms in the MTHFR, DPYD, UMPS, ABCB1, ABCC2, GSTP1, ERCC1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ziyu, Xing, Xiaofang, Shan, Fei, Li, Shuangxi, Li, Zhongwu, Xiao, Aitang, Xing, Zhaodong, Xue, Kan, Li, Zhemin, Hu, Ying, Jia, Yongning, Miao, Rulin, Zhang, Lianhai, Bu, Zhaode, Wu, Aiwen, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342428/ https://www.ncbi.nlm.nih.gov/pubmed/27487151 http://dx.doi.org/10.18632/oncotarget.10961

Ejemplares similares

Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
por: Li, Ziyu, et al.
Publicado: (2018)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial
por: Li, Ziyu, et al.
Publicado: (2018)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis
por: Li, Ziyu, et al.
Publicado: (2017)

Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
por: Liu, Zining, et al.
Publicado: (2021)

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
por: Li, Ziyu, et al.
Publicado: (2020)

Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study
por: Li, Ziyu, et al.
Publicado: (2015)

Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials
por: Lei, Xiaokang, et al.
Publicado: (2022)

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study
por: Wang, Yinkui, et al.
Publicado: (2022)

Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial
por: Li, Ziyu, et al.
Publicado: (2016)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
por: Yuan, Peng, et al.
Publicado: (2019)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
por: Yang, Yang, et al.
Publicado: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice
por: Zhang, Lianhai, et al.
Publicado: (2015)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients
por: Zheng, Zhixue, et al.
Publicado: (2016)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
por: Zhang, Meng, et al.
Publicado: (2023)

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013)

Clinicopathological and Immunomicroenvironment Characteristics of Epstein–Barr Virus-Associated Gastric Cancer in a Chinese Population
por: Jia, Xiaoxia, et al.
Publicado: (2021)

Molecular characteristics of synchronous multiple gastric cancer
por: Wang, Anqiang, et al.
Publicado: (2020)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

Correction: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2014)

Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
por: Ming, Jiao, et al.
Publicado: (2023)

DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance
por: Wang, Xiaohong, et al.
Publicado: (2022)

PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
por: Xing, Xiaofang, et al.
Publicado: (2014)

A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Comments on Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English edition)
por: Bu, Zhaode, et al.
Publicado: (2020)

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection
por: Wang, Xiaohong, et al.
Publicado: (2017)

Surgical treatment of gastric cancer: Current status and future directions
por: Chen, Jiahui, et al.
Publicado: (2021)

A commentary on: “A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells” – tumor microenvironment: the Achilles heel of cancer
por: Wei, Jingtao, et al.
Publicado: (2022)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients
por: Chen, Qi, et al.
Publicado: (2017)

Double Tract Reconstruction Reduces Reflux Esophagitis and Improves Quality of Life after Radical Proximal Gastrectomy for Patients with Upper Gastric or Esophagogastric Adenocarcinoma
por: Ji, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g75jleteflg5grl414a4nmpp5p